Abstract Multiple sclerosis (MS) is characterized as an autoimmune demyelinating disease. Numerous family studies have confirmed a strong genetic component underlying its etiology. After several decades of frustrating research, the advent and application of affordable genotyping of dense SNP maps in large data sets has ushered in a new era in which rapid progress is being made in our understanding of the genetics underlying many complex traits. For MS, one of the first discoveries to emerge in this new era was the association with rs6897932[T244I] in the interleukin-7 receptor alpha chain (IL7RA) gene (Gregory et al.
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Introduction
Multiple sclerosis (MS) is an idiopathic autoimmune demyelinating disease that strikes in the early to mid-adult life and affects women more often than men. MS, like most common diseases, has several complicating characteristics including clinical and genetic heterogeneity, incomplete penetrance, fluctuations over time, polygenic inheritance and substantial environmental risk factors (Compston and Coles 2002) . Numerous family and twin studies have shown that there is a strong genetic component underlying the etiology of MS. The prevalence of the disease among first-degree relatives of affected individuals is substantially increased compared to that in the general population, and twin studies suggest an overall heritability of *50% Hauser and Goodkin 1998; Mumford et al. 1994; Robertson et al. 1996; Sadovnick et al. 1993 Sadovnick et al. , 1996 Sadovnick and Ebers 1995) .
In the 1970s, the association of major histocompatibility complex (MHC) with MS was discovered (Bertrams and Kuwert 1972; Naito et al. 1972) . However, linkage screens failed to consistently identify any regions of linkage outside the MHC (Ebers et al. 1996; Haines et al. 1996; Kuokkanen et al. 1997; Sawcer et al. 1996; Transatlantic Multiple Sclerosis Genetics Cooperative 2001; International Multiple Sclerosis Genetics Consortium 2005) . Furthermore, although hundreds of candidate genes have been tested, none had gained consensus as carrying risk for MS (Hirschhorn et al. 2002) . This slow progress made it clear that more powerful approaches were needed in the genetic analysis of MS. Genomic convergence was applied to explicitly identify candidate genes with the best genetic and biological relevance (Hauser et al. 2003) . In 2007, more than 3 decades after HLA was first identified, the interleukin-7 receptor alpha chain (IL7RA or CD127) was identified as the first non-MHC MS susceptibility locus using this approach (Gregory et al. 2007 ) and simultaneously confirmed in an accompanying report (Lundmark 2007) .
The associated SNP was also identified in the first genome-wide association study (GWAS) in MS (International Multiple Sclerosis Genetics Consortium 2007) and in the non-synonymous SNP (nsSNP) screen performed by the Wellcome Trust Case Control Consortium (WTCCC) (Wellcome Trust Case Control Consortium 2007) . The original GWAS study also identified interleukin-2 receptor a gene (IL2RA or CD25) as an MS risk gene and highlighted the likely role of additional loci including CLEC16A and CD58. The effects of these additional genes were replicated in multiple independent data sets confirming their status as MS-associated loci. In addition, other genes were identified and replicated as MS risk genes, including TYK2, CD226, TNFRSF1A (or CD120a), IRF8, and CD6 (Australia and New Zealand Multiple Sclerosis Genetics Consortium 2009; Ban et al. 2009; Baranzini et al. 2009b; De Jager et al. 2009; International Multiple Sclerosis Genetics Consortium 2009a; Kumpfel et al. 2008) .
Rs6897932, a non-synonymous coding SNP in IL7RA, plays a functional role in MS, as the major allele (C) increases skipping of exon 6 and thus increases the soluble form of IL7RA. IL7RA is a likely functional candidate for this complex disease because it is involved in the development, maturation, and homeostasis of T and B cells. It is involved in two signaling pathways: IL7 and thymic stromal lymphopoietin (TSLP) (Gregory et al. 2007) .
IL7 is an essential cytokine for lymphocyte development. Its receptor consists of two components: IL7RA and IL2RG (gamma c or CD132); the latter also heterodimerizes with receptors for other interleukins, including IL2, IL4, IL9, IL15, and IL21. Both components are essential for the biological effects of IL7 and are also required for the downstream signaling cascade, which involves the activation of Janus kinases (Jaks) and signal transducer activators of transcription (STATs). The downstream signaling cascades are involved in various cell processes including development of B and T cells, regulation of cell proliferation, regulation of survival for progenitor and mature lymphoid cells, and gene transcription following an immune response (Hofmeister et al. 1999; Jiang et al. 2005) . We hypothesized that genes in the IL7RA pathway may have independent or interactive effects with the risk SNP in IL7RA (Gregory et al. 2007 ).
Other complex diseases, including schizophrenia and Crohn's disease, have employed the approach of examining the extended pathways identified through known susceptibility genes to identify new disease loci (Hennah et al. 2007; McGovern et al. 2009 ). With the prior knowledge that IL7RA is associated, it is plausible that this pathway (IL7/IL7RA) is involved in the autoimmune aspects of the disease. We designed our study to investigate the role of genes in the IL7RA pathway in MS susceptibility, both for independent and interactive gene effects. We selected genes as part of this pathway if they were directly involved in the downstream signaling cascade or were known to be influenced by varying IL7 concentrations.
Results
After all quality control was completed, the discovery data set consisted of 7,637 ) based on what we could reasonably follow-up on in a replication study. To get better coverage of those five regions of particular interest, we included additional SNPs giving us a total of 31 SNPs.
Following QC analyses, 24/31 SNPs were analyzed in the independent validation data set of 2,111 cases and 2,037 controls. We observed 11/24 significant SNPs (p values \ 0.05) with estimated GRRs of 1.11-1.25 (Table 2 ). In addition, we merged the two independent data sets together to obtain the overall Armitage p values for all 3,454 cases and 3,416 controls. The SNPs on chromosome 16 flanking SOCS1 were the most significant, having an estimated GRR of 1.25; the most significant p value (3.48 9 10 -7 ) was with SNP rs441349. IL7 also had significant SNPs as well with estimated GRRs of 1.14 and 1.35 (Table 3) with p values of 6.92 9 10 -4 and 8.29 9 10 -6 for SNPs rs1054283 and rs2587156, respectively. Because gender ratios in the replication data set were different from the discovery set, we also examined the stratified data set to confirm that gender was not a confounding variable. We saw no differences in the gender-specific results ( Table 4 ). The high-risk allele frequency of the associated IL7RA variant meant that our analysis based on stratifying according to this locus had only limited power. It was thus not surprising that no novel finding emerged. The HLA stratified data was more interesting. There were 2,584/6,870 individuals with at least one risk allele (''A'' allele for rs3135388) (IMSGC 2007) . The Armitage trend test for those individuals without a risk allele showed that IL7 had more significant p values than in the overall data set. For those individuals with the risk allele (at least one copy), SNPs in the flanking region of SOCS1 yielded the most significant p values for the Armitage trend test (Table 5) . However, a test of heterogeneity was only significant for the SNPs in IL7 (p values = 0.03-0.04).
Discussion
Through our analysis of the genes implicated as part of the IL7R pathway, we identified two novel gene regions, IL7 and SOCS1, replicated these in an independent data set and had highly significant overall results. Finding association with the biologically relevant ligand (IL7) of IL7R indicates that the known biological activity of these genes is relevant to MS, as opposed to some perhaps as yet unknown pleiotropic effect of these genes. The IL7/IL7R complex, along with IL2RG, is vital for the development, maturation, and survival of T cells, which is theorized to occur when the breakdown in the body's immune response occurs. This breakdown could, therefore, play a role in the adverse autoimmunity found in MS patients (Goverman 2009) .
Interestingly, SOCS1 is located on chromosome 16, slightly downstream from a recently confirmed MS susceptibility locus, CLEC16A. After examining the linkage disequilibrium (LD) architecture of this region, SOCS1 and CLEC16A appear to be two independent MS disease loci [the r 2 values between the CLEC16A SNP (rs7184083), and the most significant SNPs in the SOCS1 region are 0.057 (rs1640923) and 0.049 (rs12922733)]. The LD block containing CLEC16A is separated from the more proximal LD block containing the SOCS1 gene region, which contains our significant SNPs. Having an associated SNP in the flanking region of a gene involved in suppression of cytokine signaling (i.e., SOCS1 functions as a suppressor of cytokine signaling) suggests that this flanking region could be a regulatory element. Having multiple associated Hum Genet (2010) 127:525-535 527 genes in close proximity may suggest that these genes could be co-regulated. These observations warrant further investigation of this region via functional studies. We also identified three additional strong candidate genes that have biological relevance to the etiology of MS, including protein kinase C epsilon (PRKCE), B cell lymphoma 2 (BCL2), and tyrosine kinase 2 (Tyk2). PRKCE is involved in neuron channel activation and apoptosis. BCL2 is involved in activation of apoptosis. Tyk2 transmits cytokine signals by phosphorylating receptor subunits (Jiang et al. 2005; Shirai et al. 2008) . Through independent efforts, we have already identified Tyk2 as a susceptibility gene in MS. Its re-emergence here thus provides a valuable positive control and further support for the importance of Tyk2 (Ban et al. 2009 ).
The results indicate that the multiple genetic variations in the IL7/IL7RA pathway are important in MS pathogenesis and, by implication, that this pathway plays an important biological role in the etiology of MS. Furthermore, our data support the approach of using candidate pathways as an effective way of identifying additional MS susceptibility genes. Examining the extended pathways of previously identified associated genes has recently proven useful in the identification of new disease loci (Hennah et al. 2007; McGovern et al. 2009 ). Therefore, this method of screening the biologically interacting genes of confirmed disease genes may help to elucidate additional aspects of the underlying genetic architecture of numerous complex diseases.
These data have also identified several genes that have modest significance and should be examined further. Some of the genes mentioned previously (i.e., PRKCE and BCL2) should be investigated in independent data sets. They were not strongly replicated, but had several SNPs with nominally significant p values in the discovery data set and trending favorably in the validation data set. Thus, additional examination of these genes is necessary. Additionally, other genes (i.e., PRKCA, Stat5a/b, IL12A/B, T-BET, BAX, and BIM) also had several SNPs with interesting trends that were not followed up in this study. All of these genes have biological plausibility and need further exploration.
The HLA-DR*1501 allele identified decades ago confers a much larger effect on MS susceptibility [odds ratio (OR) *3] than the effects of recently identified associations. Both the IL7RA and the IL2RA alleles have much smaller effects (OR *1.2 and OR *1.25, respectively) (Gregory et al. 2007; International Multiple Sclerosis Genetics Consortium 2007) . It is possible that common alleles with smaller effects could explain a significant proportion of the genetic component of MS (Baranzini et al. 2009a; Sawcer 2008; Wang et al. 2005) . In this study of the IL7/IL7RA pathway, the nominally significant SNPs all have estimated GRRs of 1.11-1.64, and over 75% have GRRs \1.20. Using the pathway approach in conjunction with these large data sets and dense SNP genotyping, the etiology of MS is finally starting to be dissected. By building on the knowledge of these smaller gene effects, functional studies can help us understand the underlying mechanism of these genes and their relationships with the pathogenesis of MS.
Methods

Samples
Samples for the discovery screen came from both the USA and the UK. Through the International Multiple Sclerosis Genetics Consortium (IMSGC), we compiled a total of 2,961 samples (1,479 cases and 1,482 controls). The McDonald criteria were used to provide a positive diagnosis for MS (McDonald et al. 2001) . Healthy, unrelated controls were selected from the same US sites and from the 1958 Birth Cohort in the UK. Controls were selected to match the appropriate ratio of female to male cases. Controls were also age matched to the cases when possible. Subjects were chosen with all four main types of MS and varying disability. In the UK subset, those with clinically isolated syndrome (CIS) were excluded from this study; however, about 7% of the US subset had CIS at their examination dates, as the US experience indicates that these individuals virtually always develop MS. All participants self-reported as non-Hispanic whites. The table of the demographics of these samples can be found elsewhere (Table 4 of International Multiple Sclerosis Genetics Consortium 2009b). Samples for the replication data set also were obtained from the USA and the UK through the IMSGC. The same criteria were applied for diagnosis (McDonald et al. 2001 ). The controls were collected from the same ascertainment sites as the cases with the UK controls coming from the 1958 Birth Cohort. Like the discovery data set, the UK cases with CIS were removed, whereas CIS cases only made up 4% of the US cases. All samples were selfreported non-Hispanic whites. This data set consisted of 4,831 samples (2,397 cases and 2,434 controls) (Table 6 ). Genotype concordance tests were performed to exclude any possible duplicate samples, thereby ensuring that the two data sets (discovery data set and the replication data set) were independent.
Genotyping
We identified 73 genes demonstrating putative biological involvement within the IL7RA pathway (Table 7) by performing a PubMed search (Ansel et al. 2006; Fry and Mackall 2005; Gregory et al. 2007; Hofmeister et al. 1999; Jiang et al. 2004 Jiang et al. , 2005 Kisseleva et al. 2002; Motsinger et al. 2007; O'Shea 2004) . All known SNPs within the genomic sequence of each gene and 50 kb flanking upstream and downstream of the gene were identified using dbSNP version 127 (for complete coordinates of these genes see Suppl. Table 2 ). The flanking regions of each gene were included to thoroughly examine the gene and any possible regulatory regions surrounding the gene. We used the Illumina Infinium 60K BeadChip assay as our genotyping platform (Steemers et al. 2006) for the initial screening experiment. Both case and control samples were included on each BeadChip in a randomized order. With additional collaborators from the IMSGC, we aggregated a total of 48,767 SNPs for multiple projects into a single 60K BeadChip design. This study selected and used 7,865 SNPs for the 73 gene regions. These SNPs represented 16% of the total 60K BeadChip. The criteria for picking SNPs were: minor allele frequencies greater than 5%, validated SNPs (from dbSNP), and Illumina Infinium score greater than 0.60 (proprietary score used to determine the overall success of the assay). The Illumina protocol involves amplification of genomic DNA, fragmentation of this DNA, hybridization of the DNA on the BeadChip, extension on the BeadChip, and imaging to read the chip (Steemers et al. 2006) .
For the validation experiment, the Sequenom MassAR-RAY iPLEX platform was used. The Sequenom protocol involves a multiplex PCR reaction preceding a single base primer extension reaction. The individual SNPs are identified by using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI TOF MS). The protocol for this platform is described in detail elsewhere (Gabriel et al. 2009 ). In total, 90 SNPs were genotyped across three Sequenom pools for the aggregated multiple IMSGC projects. This study selected 31 SNPs across 5 gene regions. The SNPs chosen for replication were those with the highest Armitage p values and were derived from five biologically relevant gene regions. Quality control (QC)
Upon completion of genotyping, QC processes were run for the entire BeadChip to guarantee the accuracy of the genotyped data set. The discovery data set contained 2,961 individuals (1,479 cases and 1,482 controls). Using the Whole-genome Association Study Pipeline (WASP) (Sexton et al. 2007), we tested for SNP and sample genotyping efficiency, allele frequencies, gender errors, and HardyWeinberg equilibrium (HWE). To ensure thorough cleaning of the data, this process was performed recursively. Overall, individuals were dropped based on low genotyping efficiency (\95%), gender discrepancies (X-chromosome heterozygosity scores), apparent relatedness (using IBS statistics in graphical relationship representation), and population stratification (using structure). In total, 239 individuals were eliminated: 92 based on low genotyping efficiency, 68 based on gender discrepancies and/or apparent relatedness, and 79 based on population stratification. Over 800 X-chromosome SNPs were on the BeadChip and could be used to determine possible gender discrepancies. Population stratification was investigated, and samples were dropped if the probability was \0.90 of being from European descent. SNPs were eliminated based on low genotyping efficiency (\95%), on the absence of a minor allele in our data set (monomorphic), and on the deviation from HWE (\0.0001). Seventy-three SNPs were out of HWE in the overall data set, but were in HWE ([0.05) in either the cases alone or the controls alone and were subsequently retained for analysis. After application of stringent QC, we eliminated *8% of the samples and *4% of the SNPs. The estimate of residual genotypic error (based on X-chromosome heterozygosity in males) was 1.87 9 10 -3 . Overall, QC was completed yielding 2,722 individuals (1,343 cases and 1,379 controls) and 46,874 SNPs. This QC process was the same for this experiment and for an extensive follow-up of GWAS data from the IMSGC (International Multiple Sclerosis Genetics Consortium 2009b). This project included 7,637 SNPs (16.3% of the total BeadChip SNPs passing QC).
Similar QC processes were applied to the 31 SNPs in the replication phase. The replication data set contained 4,831 individuals (2,398 cases and 2,433 controls). Using the WASP, we tested for marker and sample genotyping efficiency, allele frequencies, and Hardy-Weinberg equilibrium (HWE). Overall, 474 individuals were eliminated based on low genotyping efficiency (\85%) or the individuals self-reporting as other than non-Hispanic Caucasians. In addition, 219 individuals were eliminated due to overlap with the discovery data set. No X-chromosome SNPs were run, so gender discrepancies could not be addressed, and there were not enough SNPs genotyped to look at sample relatedness. Markers were eliminated based on low genotyping efficiency (\95%) and deviation from HWE (\0.0001). Four SNPs had genotyping efficiencies lower than 95%, and three SNPs were out of HWE. The QC process eliminated *14.3% of the samples and *22.5% of the SNPs. Overall, QC was completed yielding 4,148 individuals (2,111 cases and 2,037 controls) and 24 SNPs.
Analysis
Armitage trend tests and genotypic chi square analyses were performed using WASP software for the minor allele. In addition, haplotype blocks were identified and examined for haplotypic associations using HaploView (Barrett et al. 2005 ) and haplo.stats from the R-project (http://www. r-project.org/). The Armitage trend test and genotypic chi square analyses were performed for all 7,637 SNPs on all individuals using an additive scoring model for the minor allele. The haplotypic analysis was performed on the ''tagging SNPs'' that tag (using r 2 value = 0.80) only the 578 nominally significant (p values \ 0.05) SNPs from the Armitage trend test on all individuals. Rs3135388, a SNP that is highly predictive of the HLA-DRB1*1501 allele, was included on the chip for purposes of secondary analyses such as stratification and interactive effects (International Multiple Sclerosis Genetics Consortium 2007). We also included the rs6897932 SNP in IL7RA. Stratification by this SNP was used to explore possible interactions as previously suggested (Gregory et al. 2007 ).
The replication data set had an unequally distributed sex ratio (Table 6) ; thus, to ensure that there was not a possible confounder, we stratified our data set by gender to see if there were differences in the results.
We report nominal p values (p values \ 0.05) (unless otherwise indicated). A stringent Bonferroni corrected p value is 2.0 9 10 -5 calculated using *2,500 independent SNPs (given the linkage disequilibrium in each gene region using an r 2 value = 0.80). MDR was used to look for gene-gene interactions within the pathway (Ritchie et al. 2001) . We have adequate power ([80%) in the discovery data set to obtain odds ratios of 1.3 and greater.
